Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Clinical Trials

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

Chemoradiotherapy before surgery may extend lives of pancreatic cancer patients

Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery.

Combining heartburn drugs and aspirin could help prevent oesophageal cancer in people at high risk

Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease.

Some people with advanced kidney cancer could avoid surgery

The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer.

Breast cancer gene test could spare some women chemo

A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy.

Trial to test new treatment combination for children and adults with leukaemia

A clinical trial testing a new treatment combination in patients with leukaemia launches through the Combinations Alliance today.

Six months of breast cancer treatment ‘could be as effective as 12’ in some women with early stage disease

Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results.

Science Surgery: ‘What’s being done to use treatments in different types of cancer?’

In this Science Surgery post we explore the work being done to use existing treatments in other types of cancer.

Precision drug could treat different cancers with rare gene fault  

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results.

Cancer Research UK to invest £45 million in clinical trials

Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the UK.

Pages